Uncategorized - February 20, 2015
Uppsala Doctor Receives Grant
A cardiologist at Sweden’s University Hospital and Uppsala Clinical Research Center received a 300 000 kronor grant to study the incidence of spontaneous coronary artery dissection in women with heart attacks and the prognosis for these patients. While spontaneous coronary artery dissection is a rare cause of a heart attack, most of those stricken are young […]
Uncategorized - February 20, 2015
Positive Phase 2 Trial for Oral Insulin
Novo Nordisk has successfully completed the phase 2 trial for OG217SC, an oral formulation of the long-acting GLP-1 analogue semaglutidea, a form of oral insulin, sending its stock shares climbing. Semaglutide appeared to have “a safe and well-tolerated profile,” according to Novo Nordisk. The 26-week trial included tests of dose range, escalation, efficacy and safety of once-daily doses […]
Acquisition - February 19, 2015
AZ Books UK–Sweden Flight
Beginning in March, AstraZeneca will pay for Scandinavian airline Sun Air to make the one-hour flight from Cambridge to Gothenburg’s Landvetter airport Monday to Thursday mornings, and return in the early evening, to link the company’s two research hubs. AstraZeneca has agreed to pay for 20 seats on each flight, but the remaining 12 will be open […]
Uncategorized - February 19, 2015
Link Between Type 2 Diabetes, Alzheimer’s
Having type 2 diabetes could increase one’s chances of developing Alzheimer’s Disease, according to a study by researchers at Uppsala University in Sweden. The risk comes from amyloid deposits that characterize Alzheimer’s disease forming in the pancreas of type 2 diabetics. Both diseases are characterized by a process called amyloidosis, in which misfolded proteins accumulate into fibrous […]
Acquisition - February 18, 2015
Revenio, Tide Sign Agreement
Revenio Group Corporation has signed a license agreement with Tide Medical Oy for a patented invention to diagnose asthma. The agreement allows Revenio to use this invention to develop and commercialize products related to the screening, diagnosis, monitoring and treatment of asthma. It likelywill take several years before the products become commercially significant for the company. “Our […]
MedTech Business - February 18, 2015
Mendor Smart Meter Gets CE Approval
Finnish company Mendor, which specializes in diabetes technology, received a CE approval for its wireless and cellular (3G) glucose meter Mendor Smart. Mendor Smart automatically transmits glucose readings to Mendor’s cloud software for further analysis, storing and sharing. The meter is also equipped with programmable reminders and messages to help people with diabetes manage their […]
